Association of blood cotinine level with cognitive and physical performance in non-smoking older adults

Environmental Research

Volumn 121, Issue , 2013, Pages 64-70

  Akhtar, Wajiha Z ^a   Andresen, Elena M ^a,b   Cannell, Michael B ^a   Xu, Xiaohui ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aging; Cognition; Environmental tobacco smoke; Older adults; Secondhand smoke

Indexed keywords

ALCOHOL; COTININE; LEAD;

ADULT; AGING; ASSESSMENT METHOD; BLOOD; COGNITION; CROSS SECTION; DATA SET; DIABETES; HYPERTENSION; PERFORMANCE ASSESSMENT; REGRESSION ANALYSIS; SMOKING;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTHRITIS; ARTICLE; BLOOD LEVEL; BODY MASS; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; COGNITION; CONFUSION; CONGESTIVE HEART FAILURE; CORRELATIONAL STUDY; COTININE BLOOD LEVEL; DIABETES MELLITUS; DIGIT SYMBOL SUBSTITUTION TEST; EDUCATIONAL STATUS; ENVIRONMENTAL EXPOSURE; FEMALE; GAIT; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEMORY DISORDER; NEOPLASM; OBESITY; PASSIVE SMOKING; PHYSICAL PERFORMANCE; POPULATION RESEARCH; POVERTY; PRIORITY JOURNAL; SELF REPORT; SMOKING; VELOCITY;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY MASS INDEX; COGNITION; COGNITION DISORDERS; CONFIDENCE INTERVALS; COTININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LEAD; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; REGRESSION ANALYSIS; SELF REPORT; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 84873998674     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2012.10.013     Document Type: Article

References (36)

1. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 2004, 43(10):1731-1737.
2. Barnes D.E., Haight T.J., Mehta K.M., Carlson M.C., Kuller L.H., Tager I.B. Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study. Am. J. Epidemiol. 2010, 171(3):292-302.
3. Barnoya J., Glantz S.A. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005, 111(20):2684-2698.
4. Burghuber O.C., Punzengruber C., Sinzinger H., Haber P., Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest 1986, 90(1):34-38.
5. Centers for Disease Control a. National Center for Health Statistics. National Health and Nutrition Examination Survey. Available: [accessed April 1 2011]. http://www.cdc.gov/nchs/nhanes.htm.
6. Centers for Disease Control b. National Center for Health Statistics. NHANES 1999-2000: Survey Operations Manuals, Brochures and Consent Documents. Available: [accessed April 1 2011]. http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/current_nhanes_99_00.htm.
7. Centers for Disease Control c. National Center for Health Statistics. NHANES 2001-2002: Survey Operations Manuals, Brochures and Consent Documents. Available: [accessed April 1 2011]. http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/current_nhanes_01_02.htm.
8. Centers for Disease Control d. National Center for Health Statistics. National Health and Nutrition Examination Survey Analytic Guidelines. Available: [accessed April 1 2011]. http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/analytical_guidelines.htm.
9. Centers for Disease Control e. National Center for Health Statistics. NHANES 1999-2000: Nutritional Biochemistries Data Documentation, Codebook, and Frequencies. Available: [accessed April 1 2011]. http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/LAB06.htm.
10. Centers for Disease Control f. National Center for Health Statistics. Laboratory Procedures Manual: Serum Cotinine. Available: [accessed April 1, 2011]. http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l06_b_met_cotinine.pdf.
11. Centers for Disease Control g. National Center for Health Statistics. National Health and Nutrition Examination Survey, Data Documentation, Codebook, and Frequencies. Cognitive Functioning (CFQ). Available: [accessed April 1 2011]. http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/CFQ.htm.
12. Cesari M., Kritchevsky S.B., Penninx B.W., Nicklas B.J., Simonsick E.M., Newman A.B., et al. Prognostic value of usual gait speed in well-functioning older people-results from the health, aging and body composition study. J. Am. Geriatr Soc. 2005, 53(10):1675-1680.
13. Environmental Protection Agency. 2010. EPA Report on the Environment: Blood Cotinine Level. Available: .viewInd&lv=list.listbyalpha&r=223968&subtop=343 [accessed April 3 2011]. http://cfpub.epa.gov/eroe/index.cfm?fuseaction=detail.
14. Feldman H.H., Jacova C., Ribillard A., Garcia A., Chow T., Borrie M., et al. Diagnosis and treatment of dementia. Diagnosis. CMAJ 2008, 178:825-836.
15. Glantz S.A., Parmley W.W. Passive smoking and heart disease. Mechanisms and risk. J. Am. Med. Assoc. 1995, 273(13):1047-1053.
16. Guralnik J.M., Ferrucci L., Pieper C.F., Leveille S.G., Markides K.S., Ostir G.V., et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J. Gerontol A. Biol. Sci. Med. Sci. 2000, 55(4):M221-231.
17. Iso H., Shimamoto T., Sato S., Koike K., Iida M., Komachi Y. Passive smoking and plasma fibrinogen concentrations. Am. J. Epidemiol. 1996, 144(12):1151-1154.
18. Jeemon P., Agarwal S., Ramakrishnan L., Gupta R., Snehi U., Chaturvedi V., et al. Validation of self-reported smoking status by measuring serum cotinine levels: an Indian perspective. Natl. Med. J. India 2010, 23(3):134-136.
19. Juan D., Zhou D.H., Li J., Wang J.Y., Gao C., Chen M. A 2-year follow-up study of cigarette smoking and risk of dementia. Eur. J. Neurol. 2004, 11(4):277-282.
20. Launer L.J., Andersen K., Dewey M.E., Letenneur L., Ott A., Amaducci L.A., et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999, 52(1):78-84.
21. Laurin D., Masaki K.H., Foley D.J., White L.R., Launer L.J. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia aging study. Am. J. Epidemiol. 2004, 159(10):959-967.
22. Law M.R., Morris J.K., Wald N.J. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 1997, 315(7114):973-980.
23. Lerner-Frankiel M.B., Varcas S., Brown M.B., Krusel L., Schoneberger W. Functional community ambulation: what are your criteria?. Clin. Man. Phys. Ther. 1986, 6:12-15.
24. Llewellyn D.J., Lang I.A., Langa K.M., Naughton F., Matthews F.E. Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement. Br. Med. J. 2009, 338:b462.
25. Newman A.B., Fitzpatrick A.L., Lopez O., Jackson S., Lyketsos C., Jagust W., et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the cardiovascular health study cohort. J. Am. Geriatr. Soc. 2005, 53(7):1101-1107.
26. Otsuka R., Watanabe H., Hirata K., Tokai K., Muro T., Yoshiyama M., et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. J. Am. Med. Assoc. 2001, 286(4):436-441.
27. Ott A., Andersen K., Dewey M.E., Letenneur L., Brayne C., Copeland J.R., et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004, 62(6):920-924.
28. Perera S., Studenski S., Chandler J.M., Guralnik J.M. Magnitude and patterns of decline in health and function in 1 year affect subsequent 5-year survival. J. Gerontol. A. Biol. Sci. Med. Sci. 2005, 60(7):894-900.
29. Proust-Lima C., Amieva H., Dartigues J.F., Jacqmin-Gadda H. Sensitivity of four psychometric tests to measure cognitive changes in brain-aging-population-based studies. Am. J. Epidemiol. 2006, 165:344-350.
30. Rosano C., Newman A.B., Katz R., Hirsch C.H., Kuller L.H. Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J. Am. Geriatr. Soc. 2008, 56(9):1618-1625.
31. Schmid P., Karanikas G., Kritz H., Pirich C., Stamatopoulos Y., Peskar B.A., et al. Passive smoking and platelet thromboxane. Thromb. Res. 1996, 81(4):451-460.
32. Studenski S., Perera S., Patel K., Rosano C., Faulkner K., et al. Gait speed and survival in older adults. J. Am. Med. Assoc. 2011, 305(1):50-58.
33. Swan G.E., Carmelli D., LaRue A. Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study. Am. J. Epidmiol. 1995, 141(1):32-40.
34. US Department of Health and Human Services. 2011. Healthy People 2020: Tobacco Use Objectives. Available: [accessed April 3 2011]. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=41.
35. Widlansky M.E., Gokce N., Keaney J.F., Vita J.A. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 2003, 42(7):1149-1160.
36. Xu X., Cook R.L., Ilacqua V.A., Kan H., Talbott E.O. Racial differences in the effects of postnatal environmental tobacco smoke on neurodevelopment. Pediatrics 2010, 126(4):705-711.